OCM
PFE icon

Orleans Capital Management’s Pfizer PFE Stock Holding History

Orleans Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-78,809
Closed -$2.93M – 72
2019
Q4 		$2.93M Sell
78,809
-579
-0.7% -$20.6K 2.06% 17
2019
Q3 		$2.71M Sell
79,388
-5,587
-7% -$203K 2% 16
2019
Q2 		$3.49M Sell
84,975
-12,301
-13% -$488K 2.63% 6
2019
Q1 		$3.92M Sell
97,276
-5,997
-6% -$240K 3.01% 4
2018
Q4 		$4.28M Sell
103,273
-1,845
-2% -$76.6K 3.99% 2
2018
Q3 		$4.39M Buy
105,118
+1,054
+1% +$40.6K 3.01% 5
2018
Q2 		$3.58M Sell
104,064
-1,106
-1% -$37.8K 2.58% 6
2018
Q1 		$3.54M Sell
105,170
-2,159
-2% -$74.2K 2.6% 7
2017
Q4 		$3.69M Sell
107,329
-738
-0.7% -$25.2K 2.63% 10
2017
Q3 		$3.66M Sell
108,067
-5,073
-4% -$163K 2.74% 8
2017
Q2 		$3.61M Sell
113,140
-368
-0.3% -$11.6K 2.55% 7
2017
Q1 		$3.68M Sell
113,508
-606
-0.5% -$19.1K 2.57% 7
2016
Q4 		$3.52M Buy
114,114
+2,424
+2% +$74K 2.52% 8
2016
Q3 		$3.59M Buy
111,690
+527
+0.5% +$17.6K 2.49% 8
2016
Q2 		$3.71M Buy
111,163
+202
+0.2% +$6.45K 2.59% 5
2016
Q1 		$3.12M Sell
110,961
-1,063
-0.9% -$30.4K 2.35% 9
2015
Q4 		$3.43M Buy
112,024
+873
+0.8% +$27.5K 2.64% 4
2015
Q3 		$3.31M Sell
111,151
-2,166
-2% -$69.4K 2.63% 3
2015
Q2 		$3.6M Sell
113,317
-6,293
-5% -$205K 2.55% 3
2015
Q1 		$3.95M Sell
119,610
-13,678
-10% -$435K 2.57% 3
2014
Q4 		$3.94M Sell
133,288
-1,159
-0.9% -$33.2K 2.4% 5
2014
Q3 		$3.77M Sell
134,447
-1,304
-1% -$36.6K 1.85% 15
2014
Q2 		$3.82M Buy
135,751
+825
+0.6% +$23.5K 1.79% 17
2014
Q1 		$4.11M Sell
134,926
-192
-0.1% -$5.72K 2.09% 9
2013
Q4 		$3.93M Buy
135,118
+486
+0.4% +$14.1K 2.04% 9
2013
Q3 		$3.67M Sell
134,632
-2,368
-2% -$64.4K 2% 8
2013
Q2 		$3.64M Buy
+137,000
New +$3.79M 2.05% 12

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Orleans Capital Management's PFE Position: Q1 2020 in Review

Orleans Capital Management sold out of Pfizer (PFE) in Q1 2020, closing a stake of 78,809 shares — an estimated $2.93M sold.

Orleans Capital Management first reported a position in PFE in Q2 2013 and held it in 27 quarters. The position peaked at $4.39M in Q3 2018. 2,438 funds tracked by Wall St. Rank hold PFE as of Q1 2020.

  • Orleans Capital Management reported no remaining Pfizer position as of Q1 2020 after selling out during the quarter.
  • Orleans Capital Management sold 78,809 Pfizer shares in Q1 2020, an estimated $2.93M.
  • Orleans Capital Management first reported a position in Pfizer in Q2 2013 and held it in 27 quarters.
  • Orleans Capital Management's Pfizer position peaked at $4.39M in Q3 2018.
  • 2,438 funds tracked by Wall St. Rank held Pfizer as of Q1 2020.

Based on Orleans Capital Management's 13F filing for Q1 2020, filed 15 May 2020.